CRCbioscreen has a team of talented and experienced experts from the scientific and clinical research domain as well as the business domain, making it well positioned for successfully developing a new screening test for colorectal cancer
Henri Theunissen, CEO
Meike de Wit, co-founder & COO
Gerrit Meijer, co-founder & CSO
Our advisors
Jan Groen, advisor
Tim Moser, advisor